AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
INTRACELLULAR METABOLISM OF HUMAN APOLIPOPROTEIN(A) IN STABLY TRANSFECTED HEP G2 CELLS
Authors: LOBENTANZ EM KRASZNAI K GRUBER A BRUNNER C MULLER HJ SATTLER J KRAFT HG UTERMANN G DIEPLINGER H
Citation: Em. Lobentanz et al., INTRACELLULAR METABOLISM OF HUMAN APOLIPOPROTEIN(A) IN STABLY TRANSFECTED HEP G2 CELLS, Biochemistry, 37(16), 1998, pp. 5417-5425
AFAMIN AND VITAMIN-E IN CEREBROSPINAL-FLUID
Authors: ELLER P JERKOVIC L UHR M DIEPLINGER H
Citation: P. Eller et al., AFAMIN AND VITAMIN-E IN CEREBROSPINAL-FLUID, European journal of neuroscience, 10, 1998, pp. 17403-17403
INFLUENCE OF HEMATOCRIT ON THE MEASUREMENT OF LIPOPROTEINS DEMONSTRATED BY THE EXAMPLE OF LIPOPROTEIN(A)
Authors: KRONENBERG F TRENKWALDER E KRONENBERG MF KONIG P UTERMANN G DIEPLINGER H
Citation: F. Kronenberg et al., INFLUENCE OF HEMATOCRIT ON THE MEASUREMENT OF LIPOPROTEINS DEMONSTRATED BY THE EXAMPLE OF LIPOPROTEIN(A), Kidney international, 54(4), 1998, pp. 1385-1389
LIPOPROTEIN(A) CONCENTRATIONS AND APOLIPOPROTEIN(A) PHENOTYPES IN LONG-LASTING IDDM RELATIONSHIP TO SURVIVAL
Authors: AUINGER M TRENKWALDER E FEINBOCK C IRSIGLER K DIEPLINGER H KRONENBERG F
Citation: M. Auinger et al., LIPOPROTEIN(A) CONCENTRATIONS AND APOLIPOPROTEIN(A) PHENOTYPES IN LONG-LASTING IDDM RELATIONSHIP TO SURVIVAL, Diabetologia, 41, 1998, pp. 1340-1340
THE 19TH ANNUAL-MEETING OF THE EUROPEAN-LIPOPROTEIN-CLUB
Authors: STALENHOEF AFH AALTOSETALA K ARMSTRONG VW BENLIAN P DIEPLINGER H HUMPHRIES S STEINMETZ A
Citation: Afh. Stalenhoef et al., THE 19TH ANNUAL-MEETING OF THE EUROPEAN-LIPOPROTEIN-CLUB, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 2316-2325
APOLIPOPROTEIN-B, FIBRINOGEN, HDL CHOLESTEROL, AND APOLIPOPROTEIN(A) PHENOTYPES PREDICT CORONARY-ARTERY DISEASE IN HEMODIALYSIS-PATIENTS
Authors: KOCH M KUTKUHN B TRENKWALDER E BACH D GRABENSEE B DIEPLINGER H KRONENBERG F
Citation: M. Koch et al., APOLIPOPROTEIN-B, FIBRINOGEN, HDL CHOLESTEROL, AND APOLIPOPROTEIN(A) PHENOTYPES PREDICT CORONARY-ARTERY DISEASE IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 8(12), 1997, pp. 1889-1898
BIOGENESIS OF LIPOPROTEIN(A) IN HUMAN AND ANIMAL HEPATOCYTES
Authors: LOBENTANZ EM DIEPLINGER H
Citation: Em. Lobentanz et H. Dieplinger, BIOGENESIS OF LIPOPROTEIN(A) IN HUMAN AND ANIMAL HEPATOCYTES, Electrophoresis, 18(14), 1997, pp. 2677-2681
INCREASED PLASMA-CONCENTRATIONS OF LDL-UNBOUND APO(A) IN PATIENTS WITH END-STAGE RENAL-DISEASE - RAPID COMMUNICATION
Authors: TRENKWALDER E GRUBER A KONIG P DIEPLINGER H KRONENBERG F
Citation: E. Trenkwalder et al., INCREASED PLASMA-CONCENTRATIONS OF LDL-UNBOUND APO(A) IN PATIENTS WITH END-STAGE RENAL-DISEASE - RAPID COMMUNICATION, Kidney international, 52(6), 1997, pp. 1685-1692
RENOVASCULAR ARTERIOVENOUS DIFFERENCES IN LP[A] PLASMA-CONCENTRATIONSSUGGEST REMOVAL OF LP[A] FROM THE RENAL CIRCULATION
Authors: KRONENBERG F TRENKWALDER E LINGENHEL A FRIEDRICH G LHOTTA K SCHOBER M MOES N KONIG P UTERMANN G DIEPLINGER H
Citation: F. Kronenberg et al., RENOVASCULAR ARTERIOVENOUS DIFFERENCES IN LP[A] PLASMA-CONCENTRATIONSSUGGEST REMOVAL OF LP[A] FROM THE RENAL CIRCULATION, Journal of lipid research, 38(9), 1997, pp. 1755-1763
CELLULAR UPTAKE OF LIPOPROTEIN[A] BY MOUSE EMBRYONIC FIBROBLASTS VIA THE LDL RECEPTOR AND THE LDL RECEPTOR-RELATED PROTEIN
Authors: REBLIN T NIEMEIER A MEYER N WILLNOW TE KRONENBERG F DIEPLINGER H GRETEN H BEISIEGEL U
Citation: T. Reblin et al., CELLULAR UPTAKE OF LIPOPROTEIN[A] BY MOUSE EMBRYONIC FIBROBLASTS VIA THE LDL RECEPTOR AND THE LDL RECEPTOR-RELATED PROTEIN, Journal of lipid research, 38(10), 1997, pp. 2103-2110
UPTAKE OF LIPOPROTEIN(A) BY MOUSE EMBRYONIC FIBROBLASTS VIA THE LDL-RECEPTOR AND OR THE LDL RECEPTOR-RELATED PROTEIN/
Authors: REBLIN T NIEMEIER A MEYER N WILLNOW T DIEPLINGER H BEISIEGEL U GRETEN H
Citation: T. Reblin et al., UPTAKE OF LIPOPROTEIN(A) BY MOUSE EMBRYONIC FIBROBLASTS VIA THE LDL-RECEPTOR AND OR THE LDL RECEPTOR-RELATED PROTEIN/, Atherosclerosis, 134(1-2), 1997, pp. 147-147
DISCREPANCY BETWEEN WHOLE-BLOOD AND PLASMA-CONCENTRATIONS OF LP(A)
Authors: TRENKWALDER E KRONENBERG MF KONIG P DIEPLINGER H KRONENBERG F
Citation: E. Trenkwalder et al., DISCREPANCY BETWEEN WHOLE-BLOOD AND PLASMA-CONCENTRATIONS OF LP(A), Atherosclerosis, 134(1-2), 1997, pp. 151-151
AFAMIN IS A VITAMIN-E BINDING-PROTEIN
Authors: JERKOVIC L CHWATAL S DEJORI N LOBENTANZ EM ELLER P KRONENBERG F BAIER G DIEPLINGER H
Citation: L. Jerkovic et al., AFAMIN IS A VITAMIN-E BINDING-PROTEIN, Atherosclerosis, 134(1-2), 1997, pp. 203-203
LDL-UNBOUND APOLIPOPROTEIN(A) AND CAROTID ATHEROSCLEROSIS IN HEMODIALYSIS-PATIENTS
Authors: KRONENBERG F TRENKWALDER E STURM W KATHREIN H KONIG P NEYER U GROCHENIG E UTERMANN G DIEPLINGER H
Citation: F. Kronenberg et al., LDL-UNBOUND APOLIPOPROTEIN(A) AND CAROTID ATHEROSCLEROSIS IN HEMODIALYSIS-PATIENTS, Clinical genetics, 52(5), 1997, pp. 377-386
URINARY-EXCRETION OF APO(A) FRAGMENTS - ROLE IN APO(A) CATABOLISM
Authors: KOSTNER KM MAURER G HUBER K STEFENELLI T DIEPLINGER H STEYRER E KOSTNER GM
Citation: Km. Kostner et al., URINARY-EXCRETION OF APO(A) FRAGMENTS - ROLE IN APO(A) CATABOLISM, Arteriosclerosis, thrombosis, and vascular biology, 16(8), 1996, pp. 905-911
LIPOPROTEIN(A) IN STORED PLASMA SAMPLES AND THE RAVAGES OF TIME - WHYEPIDEMIOLOGIC STUDIES MIGHT FAIL
Authors: KRONENBERG F TRENKWALDER E DIEPLINGER H UTERMANN G
Citation: F. Kronenberg et al., LIPOPROTEIN(A) IN STORED PLASMA SAMPLES AND THE RAVAGES OF TIME - WHYEPIDEMIOLOGIC STUDIES MIGHT FAIL, Arteriosclerosis, thrombosis, and vascular biology, 16(12), 1996, pp. 1568-1572
LIPOPROTEIN(A) IN HEALTH AND DISEASE
Authors: KRONENBERG F STEINMETZ A KOSTNER GM DIEPLINGER H
Citation: F. Kronenberg et al., LIPOPROTEIN(A) IN HEALTH AND DISEASE, Critical reviews in clinical laboratory sciences, 33(6), 1996, pp. 495-543
LIPOPROTEIN(A) IN RENAL-DISEASE
Authors: KRONENBERG F UTERMANN G DIEPLINGER H
Citation: F. Kronenberg et al., LIPOPROTEIN(A) IN RENAL-DISEASE, American journal of kidney diseases, 27(1), 1996, pp. 1-25
THE NUMBER OF IDENTICAL KRINGLE IV REPEATS IN APOLIPOPROTEIN(A) AFFECTS ITS PROCESSING AND SECRETION BY HEPG2 CELLS
Authors: BRUNNER C LOBENTANZ EM PETHOSCHRAMM A ERNST A KANG C DIEPLINGER H MULLER HJ UTERMANN G
Citation: C. Brunner et al., THE NUMBER OF IDENTICAL KRINGLE IV REPEATS IN APOLIPOPROTEIN(A) AFFECTS ITS PROCESSING AND SECRETION BY HEPG2 CELLS, The Journal of biological chemistry, 271(50), 1996, pp. 32403-32410
LIPOPROTEIN METABOLISM IN RENAL REPLACEMENT THERAPY - A REVIEW (VOL 32, PG 371, 1996)
Authors: KRONENBERG F DIEPLINGER H KONIG P UTERMANN G
Citation: F. Kronenberg et al., LIPOPROTEIN METABOLISM IN RENAL REPLACEMENT THERAPY - A REVIEW (VOL 32, PG 371, 1996), Israel journal of medical sciences, 32(9), 1996, pp. 796-796
LIPOPROTEIN METABOLISM IN RENAL REPLACEMENT THERAPY - A REVIEW
Authors: KRONENBERG F DIEPLINGER H KONIG P UTERMANN G
Citation: F. Kronenberg et al., LIPOPROTEIN METABOLISM IN RENAL REPLACEMENT THERAPY - A REVIEW, Israel journal of medical sciences, 32(6), 1996, pp. 371-389
APOLIPOPROTEIN-A-IV POLYMORPHISM IN THE HUNGARIAN POPULATION - GENE-FREQUENCIES, EFFECT ON LIPID-LEVELS, AND SEQUENCE OF 2 NEW VARIANTS
Authors: MENZEL HJ DIEPLINGER H SANDHOLZER C KARADI I UTERMANN G CSASZAR A
Citation: Hj. Menzel et al., APOLIPOPROTEIN-A-IV POLYMORPHISM IN THE HUNGARIAN POPULATION - GENE-FREQUENCIES, EFFECT ON LIPID-LEVELS, AND SEQUENCE OF 2 NEW VARIANTS, Human mutation, 5(1), 1995, pp. 58-65
MULTICENTER STUDY OF LIPOPROTEIN(A) AND APOLIPOPROTEIN(A) PHENOTYPES IN PATIENTS WITH END-STAGE RENAL-DISEASE TREATED BY HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
Authors: KRONENBERG F KONIG P NEYER U AUINGER M PRIBASNIG A LANG U REITINGER J PINTER G UTERMANN G DIEPLINGER H
Citation: F. Kronenberg et al., MULTICENTER STUDY OF LIPOPROTEIN(A) AND APOLIPOPROTEIN(A) PHENOTYPES IN PATIENTS WITH END-STAGE RENAL-DISEASE TREATED BY HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Journal of the American Society of Nephrology, 6(1), 1995, pp. 110-120
INFLUENCE OF VARIOUS HEPARIN PREPARATIONS ON LIPOPROTEINS IN HEMODIALYSIS-PATIENTS - A MULTICENTER STUDY
Authors: KRONENBERG F KONIG P NEYER U AUINGER M PRIBASNIG A MEISL T PINTER G DIEPLINGER H
Citation: F. Kronenberg et al., INFLUENCE OF VARIOUS HEPARIN PREPARATIONS ON LIPOPROTEINS IN HEMODIALYSIS-PATIENTS - A MULTICENTER STUDY, Thrombosis and haemostasis, 74(4), 1995, pp. 1025-1028
LOW-MOLECULAR-WEIGHT HEPARIN DOES NOT NECESSARILY REDUCE LIPIDS AND LIPOPROTEINS IN HEMODIALYSIS-PATIENTS
Authors: KRONENBERG F KONIG P LHOTTA K STEINMETZ A DIEPLINGER H
Citation: F. Kronenberg et al., LOW-MOLECULAR-WEIGHT HEPARIN DOES NOT NECESSARILY REDUCE LIPIDS AND LIPOPROTEINS IN HEMODIALYSIS-PATIENTS, Clinical nephrology, 43(6), 1995, pp. 399-404
Risultati: 1-25 | 26-41